Ofloxacin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Acute exacerbation of chronic bronchitis (AECB)
- Community-acquired pneumonia (CAP)
- Pelvic Inflammatory Disease (PID)
- Endocervical and urethral gonorrhea (note: high resistance rates in U.S. and worldwide, no longer recommended) and chlamydia infections.
- Nongonococcal urethritis and cervicitis due to C. trachomatis.
- Uncomplicated and complicated UTI
- Prostatitis due to E. coli
- Skin and soft tissue infections
- Otitis externa, chronic suppurative otitis media, otitis media (otic solution)
- Conjunctivitis, keratitis and corneal ulcers (ophthalmic solution)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: February 1, 2016
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ofloxacin
ID - 540396
A1 - Bartlett,John,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2016/02/01/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540396/all/Ofloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -